Larvol Delta - AffiniT-Therapeutics-to-Present-Preclinical-Gene-Editing-Data-from-its-Program-Targeting-KRAS-G12D-at-the-Society-for-Immunotherapy-of-Cancer-SITC-38th-Annual-Meeting

AFNT-212 - Affini-T Therap

https://www.businesswire.com/news/home/20231031001551/en/Affini-T-Therapeutics-to-Present-Preclinical-Gene-Editing-Data-from-its-Program-Targeting-KRAS-G12D-at-the-Society-for-Immunotherapy-of-Cancer-SITC-38th-Annual-Meeting

Oct 31, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next